In a recent government meeting, city officials provided a comprehensive update on the status of COVID-19 and MPOX in San Francisco, painting a picture of declining case numbers and robust vaccination efforts.
As the meeting unfolded, the atmosphere was one of cautious optimism. The latest data revealed that COVID-19 cases in the city have dropped significantly, now standing at 9.9 cases per 100,000 residents, a stark contrast to the peak of 60.9 cases seen during previous surges. Hospitalizations have also stabilized, with approximately 40 to 50 individuals currently hospitalized due to COVID-19, including just five in intensive care. This low hospitalization rate is complemented by a healthy hospital capacity, with 35 percent of ICU beds and 20 percent of acute care beds available.
Vaccination efforts have been a focal point of the city's response. An impressive 86 percent of residents have received their initial vaccine series, and 75 percent of those vaccinated have received at least one booster shot. However, the vaccination rates for children aged 0 to 4 remain concerning, with only 32 percent having received at least one dose. Despite these lower numbers, they still surpass the national average for this age group.
Turning to MPOX, officials reported a downward trend in cases, indicating that the city has moved past its peak. Approximately 32,000 initial doses of the MPOX vaccine have been administered, with 10,000 second doses given at recent high-risk events, such as the Folsom Street Fair. The city’s clinics, including the Zuckerberg clinic, are now well-stocked with vaccines, allowing for efficient and accessible vaccination for residents.
As the meeting concluded, officials expressed pride in the city's response to both COVID-19 and MPOX, highlighting the importance of continued vigilance and community engagement in vaccination efforts. With the current trajectory, San Francisco appears to be navigating these public health challenges with resilience and determination.